Testing portfolio

Testing portfolio of FREY-TOX comprises stud­ies of acute toxicology and bio­com­pat­i­bil­i­ty according to the guidelines of OECD and ISO as well as according to the European and other international Pharmacopoeias (e. g. Ph. Eur., USP, JP and KP). Moreover, FREY-TOX is specialized in developing individual surgical study designs especially for medical devices.